Corticosteroid prescribing in palliative care settings: A retrospective analysis in New Zealand

BMC Palliative Care

Volumn 13, Issue 1, 2014, Pages

  Denton, Anne ^a   Shaw, John ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Corticosteroids; Evidence based medicine; Guidelines; Hospices; Palliative care; Prescribing

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; OMEPRAZOLE; PHENYTOIN; PREDNISONE; ZOPICLONE;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CORTICOSTEROID THERAPY; DRUG INDICATION; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; GENDER; GENERAL PRACTITIONER; HOSPICE CARE; HOSPITAL PATIENT; HOSPITAL PHYSICIAN; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; SOFT TISSUE DISEASE; SWALLOWING; TENESMUS; TREATMENT DURATION; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT;

EID: 84898048400     PISSN: None     EISSN: 1472684X     Source Type: Journal    
DOI: 10.1186/1472-684X-13-7     Document Type: Article

References (50)

1. The management of brain edema in brain tumors. Kaal ECA, Vecht CJ, Curr Opin Oncol 2004 16 593 600 10.1097/01.cco.0000142076.52721.b3 15627023
2. Methylprednisolone as palliative therapy for female terminal cancer patients. Popiela T, Lucchi R, Giongo F, Eur J Cancer Clin Oncol 1989 25 1823 1829 10.1016/0277-5379(89)90354-4 2483687
3. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. Weissman DE, J Clin Oncol 1988 1988 6 543 551
4. Dexamethasone use in inpatient palliative care. Kiani M, Yip AYM, Tuffin PHR, Roberts M, Clifford RM, J Pharm Pract Res 2011 41 217 220
5. The use of corticosteroids in Swedish palliative care. Lundstrom SH, Furst CJ, Acta Oncol 2008 45 430 437
6. Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. Matsuo N, Morita T, Iwase S, J Palliat Med 2011 14 840 845 10.1089/jpm.2011.0002 21631371
7. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Mercadante S, Berchovich M, Casuccio A, Fulfaro F, Mangione S, Am J Hosp Palliat Care 2007 24 13 19 10.1177/ 1049909106295431 17347500
8. Drugs in palliative care: results from a representative survey in Germany. Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, Neuwohner K, Schulenberg D, Radbruch L, Palliat Med 2004 18 100 107 10.1191/0269216304pm852oa 15046406
9. Monitoring drug use in palliative care. Twycross R, Bergl S, John S, Lewis K, Palliat Med 1994 8 137 143 10.1177/026921639400800207 7521714
10. Corticosteroids in advanced cancer. Wooldridge JE, Anderson CM, Perry MC, Smith MB, Oncology 2001 15 225 232 11252935
11. Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. Bruera E, Moyano JR, Sala R, Rico MA, Bosnjak S, Bertolino M, Wiley J, Strasser F, Palmer JL, J Pain Symptom Manage 2004 28 381 388 10.1016/j.jpainsymman.2004.01.009 15471656
12. Action of oral methylprednisolone in terminal cancer patients: a prospective randomised double blind study. Bruera E, Roca E, Cedaro l, Carraro S, Chacon R, Cancer Treat Rep 1985 69 751 754 2410117
13. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Della Cuna GR, Pellegrini A, Piazzi M, Eur J Cancer Clin Oncol 1989 25 1817 1821 10.1016/0277-5379(89)90353-2 2698804
14. Is corticosteroid prescribing appropriate in palliative care? Shafford E, Eur J Palliat Care 2006 13 202 204
15. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care Ontario practice guidelines initiative's neuro-oncology disease site group. Loblaw DA, Perry J, Chambers A, Laperriere NJ, Clin Oncol 2005 23 2028 2037 10.1200/JCO.2005.00.067
16. Is the pharmacological treatment of cachexia possible? Bruera E, Support Care Cancer 1993 1 298 304 10.1007/BF00364967 8156247
17. Corticosteroid therapy of preterminal gastrointestinal cancer. Moertel CG, Schutt AJ, Reiteneier RJ, Hahn RG, Cancer 1974 33 1607 1609 10.1002/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V 4135151
18. Corticosteroids in advanced cancer. Twycross R, BMJ 1992 305 969 970 10.1136/bmj.305.6860.969 1458140
19. The existential impact of starting corticosteroid treatment as symptom control in advanced metastatic cancer. Lundstrom SH, Furst CJ, Friedrichsen M, Strang P, Palliat Med 2009 23 165 170 10.1177/0269216308101486 19153133
20. Corticosteroids as adjuvant analgesics. Watanabe S, Bruera E, J Pain Sympt Manage 1994 9 442 445 10.1016/0885-3924(94)90200-3
21. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? Laval G, Girardier J, Lassauniere JM, Leduc B, Haond C, Schaerer R, Palliat Med 2000 14 3 10 10.1191/026921600669298725 10717717
22. Can "steroid switching" improve steroid-induced psychosis in a patient with advanced cancer? Okishiro N, Tanimukai H, Tsuneto S, Ito N, J Palliat Med 2009 12 487 490 10.1089/jpm.2009.9628 19416050
23. Martindale: The Complete Drug Reference London: Pharmaceutical Press, Sweetman SC, 37 2011
24. Goodman and Gilman's: the pharmacological basis of therapeutics New York: McGraw-Hill, Brunton LL, Chabner BA, Kollmann BC, 12 2010
25. British Medical Association, British National Formulary 61 London: BMJ Publishing Group and Pharmaceutical Press 2011
26. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G, Pharmacology Edinburgh: Churchill Livingstone 7 2012
27. Management of the adverse effects of corticosteroids. Abbas SQ, Eur J Palliat Care 2004 11 49 52
28. Corticosteroids in palliative care. Hardy J, Eur J Palliat Care 1998 5 46 50
29. New roles for old drugs: corticosteroids. Sweeney C, Bruera E, Prog Palliat Care 2001 9 2
30. Palliative Care Expert Group, Therapeutic Guidelines: Palliative Care Melbourne: Therapeutic Guidelines 3 2010
31. Sleep disorders. Steroids cause sleep disturbance. Turner R, Elson E, BMJ 1993 306 1477 1478
32. The risks and benefits of corticosteroids in advanced cancer. Twycross R, Drug Saf 1994 11 163 178 10.2165/00002018-199411030-00003 7811399
33. Management of fatigue in cancer patients. Davis MP, Khoshknabi D, Yue GH, Curr Pain Headache Reports 2006 10 260 269 10.1007/s11916-006-0030-2
34. Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network. Klepstad P, Kaasa S, Cherny N, Hanks G, de Conno F, Research Steering Committee of the EAPC, Palliat Med 2005 19 477 484 10.1191/0269216305pm1054oa 16218160
35. A retrospective analysis of dexamethasone use in on a Canadian palliative care unit. Pilkey J, Daeninck PJ, Prog Palliat Care 2008 16 63 68 10.1179/096992608X257610
36. Malignant spinal cord compression. Rajer M, Kovac V, Radiol Oncol 2008 42 23 31
37. Role of corticosteroids in palliative care. Shih A, Jackson KC, J Pain Palliat Care Pharmacother 2007 21 69 76
38. The use and toxicity of steroids in the management of patients with brain metastases. Sturdza A, Millar BA, Bana N, Laperriere N, Pond G, Wong RKS, Bezjak A, Support Care Cancer 2008 16 1041 1048 10.1007/s00520-007-0395-8 18256860
39. Corticosteroids in terminal cancer-a prospective analysis of current practice. Hanks GWC, Trueman T, Twycross R, Postgrad Med J 1983 59 702 706 10.1136/pgmj.59.697.702 6647187
40. A retrospective observation of corticosteroid use at the end of life in a hospice. Gannon C, McNamara P, J Pain Symptom Manage 2002 24 328 334 10.1016/S0885-3924(02)00487-6 12458114
41. The use of corticosteroids in home palliative care. Mercadante S, Fulfaro F, Casuccio A, Support Care Cancer 2001 9 386 389 10.1007/s005200000218 11497394
42. Steroids in advanced cancer: survey of current practice. Needham PR, Daley AG, Lennard RF, BMJ 1992 305 999 10.1136/bmj.305.6860.999 1458150
43. A prospective survey of the use of dexamethasone on a palliative care unit. Hardy J, Rees E, Ling J, Burman R, Feuer D, Broadley K, Stone P, Palliat Med 2001 15 3 8 10.1191/026921601673324846 11212465
44. Pattern of drug use by advanced cancer patients followed at home. Mercadante S, Fulfaro F, Casuccio A, J Palliat Care 2001 17 37 40 11324183
45. Corticosteroids: useful palliative role in cancer but use with caution. Anonymous, Drug Ther Perspect 1995 5 7 9 11 10.2165/00042310-199505070-00004
46. The prescription of steroids in the terminal phase. Gannon C, Palliat Med 2001 15 522 10.1177/026921630101500614 12403514
47. Sudden withdrawal of corticosteroids: a commentary. Rousseau P, Am J Hosp Palliat Care 2004 21 169 171 10.1177/104990910402100302 15188915
48. Pharmacological treatments for fatigue associated with palliative care. Peuckmann V, Elsner F, Krumm N, Trottenburg P, Radbruch L, Cochrane Database Syst Rev 2010 10 11 CD006788
49. Reduction of cancer-related fatigue with dexamethasone: a double-blind randomized placebo-controlled trial in patients with advanced cancer. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Dalal S, Massie L, Reddy SK, Bruera E, J Clin Oncol 2013 31 25 3076 3082 10.1200/JCO.2012.44.4661 23897970
50. Palliative Care Formulary Nottingham: palliativedrugs.com, Twycross R, Wilcock A, 4 2011